← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity

CRD-A logoCrawford & Company(CRD-A)Earnings, Financials & Key Ratios

CRD-A•NYSE•Insurance & Managed Care
$9.65
$475M mkt cap·24.7× P/E·Price updated May 6, 2026
SectorFinancial ServicesIndustryInsurance BrokersSub-IndustryClaims and cost containment services
AboutCrawford & Company provides claims management and outsourcing solutions for carriers, brokers, and corporations in the United States, the United Kingdom, Europe, Canada, Australia, and internationally. The company's Crawford Loss Adjusting provides claims management services to insurance companies and self-insured entities risk including property, public liability, automobile, and marine insurances. Its Crawford TPA Solutions segment provides claims and risk management services for corporations in the self-insured or commercially-insured marketplace; desktop claim adjusting and claims evaluation services; initial loss reporting services for claimants; and loss mitigation and risk management information services, as well as administers loss funds established to pay claims. This segment also offers third party administration for workers' compensation, auto and liability, disability absence and medical management, and accident and health products. The company's Crawford Platform Solutions segment offers insurance through service lines, such as Contractor Connection and Networks, including losses caused by natural disasters, such as fires, hailstorms, hurricanes, earthquakes, floods, as well as man-made disasters, such as oil spills, and chemical releases. It also provides customer-centric solutions for various loss types comprising high-frequency and low-complexity claims to large complex repairs; and outsourced contractor management services to personal and commercial insurance carriers and consumer markets. The company was founded in 1941 and is headquartered in Atlanta, Georgia.Show more
  • Revenue$1.31B-2.0%
  • Combined Ratio94.2%-0.8%
  • Net Income$20M-26.2%
  • Return on Equity12.01%-33.3%
  • Medical Cost Ratio75.5%+4.0%
  • Operating Margin5.8%+14.6%
  • Net Margin1.49%-24.7%
  • ROA2.5%-24.5%
  • Equity / Assets22.43%+15.9%
  • Book Value per Share3.42+9.5%
  • Tangible BV/Share-1.68+21.9%
  • Debt/Equity1.58-20.8%
Technical→

CRD-A Key Insights

Crawford & Company (CRD-A) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Profitable underwriting: 94.2% combined ratio
  • ✓Good 3Y average ROE of 17.8%
  • ✓Healthy dividend yield of 3.0%

✗Weaknesses

No significant weaknesses identified

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

CRD-A Price & Volume

Crawford & Company (CRD-A) stock price & volume — 10-year historical chart

Loading chart...

CRD-A Growth Metrics

Crawford & Company (CRD-A) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years0.57%
5 Years5.28%
3 Years2.2%
TTM-3.95%

Profit CAGR

10 Years-
5 Years-7.05%
3 Years-
TTM-41.35%

EPS CAGR

10 Years-
5 Years-6.3%
3 Years-
TTM-40.12%

Return on Capital

10 Years13.09%
5 Years12.43%
3 Years14.59%
Last Year15.9%

CRD-A Recent Earnings

Crawford & Company (CRD-A) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 5/12 qtrs (42%)●Beat Revenue 7/12 qtrs (58%)
Q2 2026Latest
May 4, 2026
EPS
$0.16
Est $0.21
-22.6%
Revenue
$310M
Est $308M
+0.4%
Q2 2026
Mar 2, 2026
EPS
$0.15
Est $0.23
-33.8%
Revenue
$309M
Est $333M
-7.2%
Q4 2025
Nov 3, 2025
EPS
$0.25
Est $0.16
+54.9%
Revenue
$322M
Est $333M
-3.1%
Q3 2025
Aug 4, 2025
EPS
$0.25
Est $0.27
-6.4%
Revenue
$335M
Est $350M
-4.5%
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 4, 2026
$0.16vs $0.21-22.6%
$310Mvs $308M+0.4%
Q2 2026Mar 2, 2026
$0.15vs $0.23-33.8%
$309Mvs $333M-7.2%
Q4 2025Nov 3, 2025
$0.25vs $0.16+54.9%
$322Mvs $333M-3.1%
Q3 2025Aug 4, 2025
$0.25vs $0.27-6.4%
$335Mvs $350M-4.5%
Based on last 12 quarters of dataView full earnings history →

CRD-A Peer Comparison

Crawford & Company (CRD-A) competitors in Claims and cost containment services — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
EIG logoEIGEmployers Holdings, Inc.Direct Competitor967.26M41.3691.91-2.55%0.95%0.83%0.04
PLMR logoPLMRPalomar Holdings, Inc.Direct Competitor2.94B110.7515.4558.16%22.56%22.79%0.01
JRVR logoJRVRJames River Group Holdings, Ltd.Direct Competitor207.09M4.515.70-2.83%4.34%4.72%0.49
MCY logoMCYMercury General CorporationProduct Competitor5.32B96.029.839.44%13.68%36.48%0.25
HLNE logoHLNEHamilton Lane IncorporatedProduct Competitor4.25B88.9516.4428.73%15.56%0.40
KINS logoKINSKingstone Companies, Inc.Product Competitor257.8M16.4511.117.6%15.68%35.79%0.17
ACN logoACNAccenture plcSupply Chain108.69B174.5714.377.36%10.65%23.92%0.25
MMC logoMMCMarsh & McLennan Companies, Inc.Supply Chain85.27B174.0621.287.57%15.6%26.87%1.62

Compare CRD-A vs Peers

Crawford & Company (CRD-A) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs EIG

Most directly comparable listed peer for CRD-A.

Scale Benchmark

vs ACN

Larger-name benchmark to compare CRD-A against a more recognizable public peer.

Peer Set

Compare Top 5

vs EIG, PLMR, JRVR, MCY

CRD-A Income Statement

Crawford & Company (CRD-A) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Revenue1.16B1.12B1.05B1.02B1.14B1.23B1.32B1.34B1.31B1.3B
Revenue Growth %-1.18%-3.5%-6.71%-3%12.11%8.08%6.96%1.83%-2%-3.95%
Medical Costs & Claims842.17M808M752.77M737.32M847.43M924.87M957.85M973.42M992.21M956.47M
Medical Cost Ratio %72.37%71.95%71.86%72.56%74.39%75.12%72.73%72.59%75.5%73.65%
Gross Profit
321.54M▲ 0%
314.97M▼ 2.0%
294.85M▼ 6.4%
278.88M▼ 5.4%
291.8M▲ 4.6%
306.35M▲ 5.0%
359.07M▲ 17.2%
367.55M▲ 2.4%
321.9M▼ 12.4%
342.13M▲ 0%
Gross Margin %27.63%28.05%28.14%27.44%25.61%24.88%27.27%27.41%24.5%26.35%
Gross Profit Growth %-1.81%-2.04%-6.39%-5.42%4.64%4.99%17.21%2.36%-12.42%-
Operating Expenses251.75M242.42M227.17M218.95M244.85M255.75M286.51M299.66M245.69M275.99M
OpEx / Revenue %21.63%21.59%21.68%21.55%21.49%20.77%21.76%22.35%18.7%21.25%
Depreciation & Amortization41.66M44.08M40.51M40.11M40.18M36.1M35.74M36.2M40.04M39.98M
Combined Ratio %94%93.54%93.54%94.1%95.88%95.89%94.49%94.94%94.2%94.91%
Operating Income
69.8M▲ 0%
72.55M▲ 3.9%
67.68M▼ 6.7%
59.92M▼ 11.5%
46.95M▼ 21.6%
50.6M▲ 7.8%
72.57M▲ 43.4%
67.88M▼ 6.5%
76.21M▲ 12.3%
66.14M▲ 0%
Operating Margin %6%6.46%6.46%5.9%4.12%4.11%5.51%5.06%5.8%5.09%
Operating Income Growth %-13.9%3.95%-6.71%-11.47%-21.65%7.78%43.4%-6.45%12.26%-
EBITDA111.45M116.63M108.2M100.03M87.13M86.7M108.31M104.08M116.25M106.12M
EBITDA Margin %9.58%10.39%10.33%9.84%7.65%7.04%8.22%7.76%8.85%8.17%
Interest Expense9.91M11.4M11.52M8.19M6.98M10.97M19.81M20.3M17.97M15.81M
Non-Operating Income17.63M17.02M32.53M0-3.9M34.59M5.4M6.47M23.64M17.67M
Pretax Income
42.26M▲ 0%
44.13M▲ 4.4%
23.64M▼ 46.4%
39.09M▲ 65.4%
43.86M▲ 12.2%
5.05M▼ 88.5%
47.36M▲ 838.5%
41.11M▼ 13.2%
34.6M▼ 15.8%
32.67M▲ 0%
Pretax Margin %3.63%3.93%2.26%3.85%3.85%0.41%3.6%3.07%2.63%2.52%
Income Tax15.04M18.54M14.11M12.01M13.32M23.58M17.1M14.58M14.92M14.82M
Effective Tax Rate %35.59%42.02%59.7%30.73%30.36%467.26%36.1%35.47%43.13%45.36%
Net Income
27.66M▲ 0%
25.98M▼ 6.1%
12.48M▼ 51.9%
28.3M▲ 126.6%
30.69M▲ 8.5%
-18.3M▼ 159.6%
30.61M▲ 267.2%
26.6M▼ 13.1%
19.63M▼ 26.2%
17.86M▲ 0%
Net Margin %2.38%2.31%1.19%2.78%2.69%-1.49%2.32%1.98%1.49%1.37%
Net Income Growth %-23.08%-6.1%-51.94%126.64%8.47%-159.64%267.22%-13.11%-26.18%-41.35%
EPS (Diluted)
0.52▲ 0%
0.50▼ 3.8%
0.18▼ 64.0%
0.54▲ 200.0%
0.57▲ 5.6%
-0.37▼ 164.9%
0.62▲ 267.6%
0.53▼ 14.5%
0.39▼ 26.4%
0.36▲ 0%
EPS Growth %-22.39%-3.85%-64%200%5.56%-164.91%267.57%-14.52%-26.42%-40.12%
EPS (Basic)0.530.510.180.540.58-0.370.630.540.40-
Diluted Shares Outstanding53.2M51.96M54.06M53.38M53.98M49.47M49.59M49.74M50.07M49.4M

CRD-A Balance Sheet

Crawford & Company (CRD-A) balance sheet — assets, liabilities & shareholders' equity

Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Assets787.94M701.44M760.01M752.98M852.64M791.51M799.2M803.75M764.3M771.65M
Asset Growth %7.08%-10.98%8.35%-0.92%13.23%-7.17%0.97%0.57%-4.91%-5.9%
Total Investment Assets0000000001000K
Long-Term Investments00000000010.44M
Short-Term Investments0000000000
Total Current Assets370.37M320.85M315.21M302M345.92M351.27M369.35M374.23M352.41M186.64M
Cash & Equivalents54.01M53.12M51.8M44.66M53.23M46.01M58.36M55.41M64.08M64.44M
Receivables282.92M239.41M239.93M227.86M258.12M276.48M247.97M278.48M246.97M918.71M
Other Current Assets0000006.02M917K41.36M0
Goodwill & Intangibles283.89M254.12M222.17M208.73M289.9M247.64M255.28M262.77M255.73M1.04B
Goodwill96.92M96.89M80.64M66.54M116.53M76.62M76.72M76.37M76.57M0
Intangible Assets186.97M157.23M141.53M142.2M173.37M171.01M178.56M186.4M179.16M254.82M
PP&E (Net)41.66M34.3M133.78M145.72M133.09M121.14M111.36M99.36M82.97M0
Other Assets67.66M70.02M70.88M70.94M62.46M51.89M36.97M42.09M48.5M319.75M
Total Liabilities594.2M520.5M595.14M566.06M641.24M668.13M659.37M648.2M592.87M597.19M
Total Debt225.67M190.41M294.78M239.57M288.67M346.4M311.53M309.49M270.27M271.1M
Net Debt171.66M137.29M242.98M194.91M235.44M300.39M253.16M254.08M206.19M271.1M
Long-Term Debt199.64M167.12M148.35M111.28M163.98M211.64M194.27M200.24M150.55M200.68M
Short-Term Debt24.64M23.2M28.53M1.57M10.62M26.97M14.73M17.74M38.45M70.42M
Total Current Liabilities256.59M225.31M236.26M242.79M303.86M279.49M299.29M299.73M309.57M323.25M
Accounts Payable49.3M37.83M34.38M41.54M48.47M50.85M45.11M50.6M39.77M59.24M
Deferred Revenue37.79M30.96M28.29M27.23M32.12M29.28M35.54M36.13M33.83M33.74M
Other Current Liabilities105.02M97.69M79.81M93.24M109.24M91.9M131.08M129.18M127.97M159.85M
Deferred Taxes1000K1000K00000000
Other Liabilities114.63M106.35M99.32M94.14M60.88M67.47M62.84M57.8M55.91M73.27M
Total Equity
193.74M▲ 0%
180.95M▼ 6.6%
164.88M▼ 8.9%
186.93M▲ 13.4%
211.4M▲ 13.1%
123.38M▼ 41.6%
139.83M▲ 13.3%
155.55M▲ 11.2%
171.43M▲ 10.2%
174.46M▲ 0%
Equity Growth %21.65%-6.6%-8.88%13.37%13.09%-41.64%13.34%11.24%10.21%53.68%
Shareholders Equity182.32M171.29M159.32M186.94M211.97M124.54M141.62M157.21M173.09M176.27M
Minority Interest11.42M9.66M5.56M-11K-568K-1.17M-1.79M-1.66M-1.66M-1.82M
Retained Earnings269.69M273.61M249.55M265.25M266.37M213.09M228.56M237.95M233.71M229.96M
Common Stock55.94M55.34M53.28M53.36M51.81M48.61M49.08M49.27M48.87M48.69M
Accumulated OCI-196.48M-216.45M-206.91M-198.86M-180.44M-215.32M-218.62M-217.13M-201.74M-193.62M
Return on Equity (ROE)15.67%13.87%7.22%16.09%15.41%-10.94%23.26%18.01%12.01%10.1%
Return on Assets (ROA)3.63%3.49%1.71%3.74%3.82%-2.23%3.85%3.32%2.5%2.28%
Equity / Assets24.59%25.8%21.69%24.82%24.79%15.59%17.5%19.35%22.43%22.61%
Debt / Equity1.16x1.05x1.79x1.28x1.37x2.81x2.23x1.99x1.58x1.58x
Book Value per Share3.643.483.053.503.922.492.823.133.423.53
Tangible BV per Share-1.69-1.41-1.06-0.41-1.45-2.51-2.33-2.16-1.68-1.63

CRD-A Cash Flow Statement

Crawford & Company (CRD-A) cash flow — operating, investing & free cash flow history

Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations40.76M52.42M75.22M93.18M54.32M27.63M103.79M51.62M101.85M101.85M
Operating CF Growth %-58.77%28.61%43.49%23.88%-41.7%-49.13%275.59%-50.27%97.31%403.64%
Operating CF / Revenue %3.5%4.67%7.18%9.17%4.77%2.24%7.88%3.85%7.75%7.84%
Net Income27.22M25.59M9.53M27.07M30.55M-18.53M30.61M26.53M19.68M17.86M
Depreciation & Amortization41.66M44.08M40.51M40.11M40.18M36.1M35.74M36.2M40.04M39.98M
Stock-Based Compensation6.66M6.2M4.11M4.38M7.58M4.92M5.6M5.77M5.19M266K
Deferred Taxes-2.36M7.95M3.04M-9.01M-2.99M7.4M-12.28M-2.53M-3.33M0
Other Non-Cash Items19.6M21.33M17.48M3.91M104K38.24M4.32M-997K3.25M2.23M
Working Capital Changes-52.02M-52.72M544K26.7M-21.1M-40.49M39.79M-13.34M37.01M56.68M
Cash from Investing-81.87M6.45M-23.42M-27.04M-70.83M-57.88M-36.6M-41.65M-36.21M-34.95M
Capital Expenditures-44.91M-30.02M-8.69M-37.38M-9.22M-6.84M-4.89M00-21.59M
Acquisitions-36.03M36.69M-2.3M9.98M-46.4M-26.31M0000
Purchase of Investments0000000000
Sale/Maturity of Investments0000000000
Other Investing-926K-218K-12.44M358K-15.2M-24.73M-31.71M-41.65M-36.21M-13.36M
Cash from Financing10.34M-58.74M-53.41M-74.37M24.66M25.94M-54.68M-12.86M-57.62M-77.2M
Dividends Paid-13.7M-13.53M-13.17M-9.64M-12.66M-11.84M-12.7M-13.76M-14.33M-14.54M
Share Repurchases-7.42M-11.52M-26.21M-2.67M-19.13M-26.75M-2.73M-3.87M-10.51M-16.03M
Stock Issued1.15M1.39M0000002.04M2.04M
Debt Issuance (Net)-1000K-1000K-1000K-1000K1000K1000K-1000K1000K-1000K-2M
Other Financing34.63M-320K819K13K-4.12M-2.87M-5.75M-3.62M-5M4.57M
Net Change in Cash
-27.56M▲ 0%
-892K▲ 96.8%
-1.32M▼ 47.6%
-7.15M▼ 442.6%
9.03M▲ 226.4%
-7.04M▼ 178.0%
12.9M▲ 283.1%
-3.22M▼ 124.9%
8.22M▲ 355.5%
6.42M▲ 0%
Exchange Rate Effect3.21M-1.02M293K1.08M881K-2.74M386K-326K198K1.55M
Cash at Beginning81.57M54.01M53.12M51.8M44.66M53.69M46.65M59.55M56.33M64.55M
Cash at End54.01M53.12M51.8M44.66M53.69M46.65M59.55M56.33M64.55M64.44M
Free Cash Flow
-4.15M▲ 0%
22.4M▲ 639.2%
54.09M▲ 141.5%
55.8M▲ 3.2%
23.37M▼ 58.1%
-6.96M▼ 129.8%
67.19M▲ 1064.7%
9.97M▼ 85.2%
94.83M▲ 851.0%
109.1M▲ 0%
FCF Growth %-105.96%639.22%141.49%3.15%-58.12%-129.81%1064.74%-85.16%850.99%216.01%
FCF Margin %-0.36%1.99%5.16%5.49%2.05%-0.57%5.1%0.74%7.22%8.4%
FCF per Share-0.080.4311.050.43-0.141.350.21.891.89

CRD-A Key Ratios

Crawford & Company (CRD-A) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Combined Ratio94%93.54%93.54%94.1%95.88%95.89%94.49%94.94%94.2%94.91%
Medical Cost Ratio72.37%71.95%71.86%72.56%74.39%75.12%72.73%72.59%75.5%73.65%
Return on Equity (ROE)15.67%13.87%7.22%16.09%15.41%-10.94%23.26%18.01%12.01%10.1%
Return on Assets (ROA)3.63%3.49%1.71%3.74%3.82%-2.23%3.85%3.32%2.5%2.28%
Equity / Assets24.59%25.8%21.69%24.82%24.79%15.59%17.5%19.35%22.43%22.61%
Book Value / Share3.643.483.053.53.922.492.823.133.423.53
Debt / Equity1.16x1.05x1.79x1.28x1.37x2.81x2.23x1.99x1.58x1.58x
Revenue Growth-1.18%-3.5%-6.71%-3%12.11%8.08%6.96%1.83%-2%-3.95%

CRD-A SEC Filings & Documents

Crawford & Company (CRD-A) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 4, 2026·SEC

Material company update

Mar 31, 2026·SEC

Material company update

Mar 23, 2026·SEC

10-K Annual Reports

4
FY 2026

Mar 2, 2026·SEC

FY 2025

Mar 3, 2025·SEC

FY 2024

Mar 4, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

May 4, 2026·SEC

FY 2025

Nov 3, 2025·SEC

FY 2025

Aug 4, 2025·SEC

CRD-A Frequently Asked Questions

Crawford & Company (CRD-A) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Crawford & Company (CRD-A) saw revenue decline by 2.0% over the past year.

Yes, Crawford & Company (CRD-A) is profitable, generating $17.9M in net income for fiscal year 2025 (1.5% net margin).

Dividend & Returns

Yes, Crawford & Company (CRD-A) pays a dividend with a yield of 2.97%. This makes it attractive for income-focused investors.

Crawford & Company (CRD-A) has a return on equity (ROE) of 12.0%. This is reasonable for most industries.

Industry Metrics

Crawford & Company (CRD-A) has a combined ratio of 94.2%. A ratio below 100% indicates underwriting profitability.

Explore More CRD-A

Crawford & Company (CRD-A) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.